ArticleJournal of molecular medicine (Berlin, Germany)2006

Clinical doses of amikacin provide more effective suppression of the human CFTR-G542X stop mutation than gentamicin in a transgenic CF mouse model.

Ming Du et al.PubMed ↗Publisher ↗

No numbers read from the abstract.